Pihlajamäki J - Search Results

1

The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study.

Todorova B, Kubaszek A, Pihlajamäki J, Lindström J, Eriksson J, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M; Finnish Diabetes Prevention Study. Todorova B, et al. Among authors: pihlajamaki j. J Clin Endocrinol Metab. 2004 May;89(5):2019-23. doi: 10.1210/jc.2003-031325. J Clin Endocrinol Metab. 2004. PMID: 15126514 Clinical Trial.

2

The Ala54Thr polymorphism of the fatty acid binding protein 2 gene does not influence insulin sensitivity in Finnish nondiabetic and NIDDM subjects.

Rissanen J, Pihlajamäki J, Heikkinen S, Kekäläinen P, Kuusisto J, Laakso M. Rissanen J, et al. Among authors: pihlajamaki j. Diabetes. 1997 Apr;46(4):711-2. doi: 10.2337/diab.46.4.711. Diabetes. 1997. PMID: 9075815 No abstract available.

3

Codon 54 polymorphism of the human intestinal fatty acid binding protein 2 gene is associated with dyslipidemias but not with insulin resistance in patients with familial combined hyperlipidemia.

Pihlajamäki J, Rissanen J, Heikkinen S, Karjalainen L, Laakso M. Pihlajamäki J, et al. Arterioscler Thromb Vasc Biol. 1997 Jun;17(6):1039-44. doi: 10.1161/01.atv.17.6.1039. Arterioscler Thromb Vasc Biol. 1997. PMID: 9194752

4

The Trp64Arg polymorphism of the beta 3-Adrenergic receptor gene. Lack of association with NIDDM and features of insulin resistance syndrome.

Rissanen J, Kuopusjärvi J, Pihlajamäki J, Sipiläinen R, Heikkinen S, Vanhala M, Kekäläinen P, Kuusisto J, Laakso M. Rissanen J, et al. Among authors: pihlajamaki j. Diabetes Care. 1997 Aug;20(8):1319-23. doi: 10.2337/diacare.20.8.1319. Diabetes Care. 1997. PMID: 9250462

5

New variants in the glycogen synthase gene (Gln71His, Met416Val) in patients with NIDDM from eastern Finland.

Rissanen J, Pihlajamäki J, Heikkinen S, Kekäläinen P, Mykkänen L, Kuusisto J, Kolle A, Laakso M. Rissanen J, et al. Among authors: pihlajamaki j. Diabetologia. 1997 Nov;40(11):1313-9. doi: 10.1007/s001250050826. Diabetologia. 1997. PMID: 9389424

6

Impaired insulin-stimulated glucose oxidation and free fatty acid suppression in patients with familial combined hyperlipidemia: a precursor defect for dyslipidemia?

Karjalainen L, Pihlajamäki J, Karhapää P, Laakso M. Karjalainen L, et al. Among authors: pihlajamaki j. Arterioscler Thromb Vasc Biol. 1998 Oct;18(10):1548-53. doi: 10.1161/01.atv.18.10.1548. Arterioscler Thromb Vasc Biol. 1998. PMID: 9763525

7

The cardiac beta-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population.

Jääskeläinen P, Soranta M, Miettinen R, Saarinen L, Pihlajamäki J, Silvennoinen K, Tikanoja T, Laakso M, Kuusisto J. Jääskeläinen P, et al. Among authors: pihlajamaki j. J Am Coll Cardiol. 1998 Nov 15;32(6):1709-16. doi: 10.1016/s0735-1097(98)00448-3. J Am Coll Cardiol. 1998. PMID: 9822100 Free article.

8

Different regulation of free fatty acid levels and glucose oxidation by the Trp64Arg polymorphism of the beta3-adrenergic receptor gene and the promoter variant (A-3826G) of the uncoupling protein 1 gene in familial combined hyperlipidemia.

Pihlajamäki J, Rissanen J, Valve R, Heikkinen S, Karjalainen L, Laakso M. Pihlajamäki J, et al. Metabolism. 1998 Nov;47(11):1397-402. doi: 10.1016/s0026-0495(98)90312-2. Metabolism. 1998. PMID: 9826220

9

Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women.

Valve R, Sivenius K, Miettinen R, Pihlajamäki J, Rissanen A, Deeb SS, Auwerx J, Uusitupa M, Laakso M. Valve R, et al. Among authors: pihlajamaki j. J Clin Endocrinol Metab. 1999 Oct;84(10):3708-12. doi: 10.1210/jcem.84.10.6061. J Clin Endocrinol Metab. 1999. PMID: 10523018

10

Impaired free fatty acid suppression during hyperinsulinemia is a characteristic finding in familial combined hyperlipidemia, but insulin resistance is observed only in hypertriglyceridemic patients.

Pihlajamäki J, Karjalainen L, Karhapää P, Vauhkonen I, Laakso M. Pihlajamäki J, et al. Arterioscler Thromb Vasc Biol. 2000 Jan;20(1):164-70. doi: 10.1161/01.atv.20.1.164. Arterioscler Thromb Vasc Biol. 2000. PMID: 10634813

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

269 results

Search Page

Filters